Table 1.
Source of exosomes | Material | Object | Role | Reference |
---|---|---|---|---|
CD8+T cells | mRNA, miRNA | Malignant tumor | Affects tumor development | (98) |
miR-765/PLP2 | UCEC | Inhibition of estrogen to promote UCEC | (99) | |
CD4+T cells | FasL | T cells | Induced T cell apoptosis and immune disorders | (100) |
miRNA-150 | Lymphoid tissue | Serum markers | (101) | |
B cells | DC vaccine | T cells | Inhibition of immune suppressive cytokine production | (102) |
NK cells | Perforin Fas/FasL | Tumor cells | Cytotoxicity, tumor cell apoptosis | (103) |
Immune components | Tumor cells | Immunomodulatory, reverse tumor immune suppression | (104) | |
DCs | MHC I, MHCII | TME | The immune response is dysfunctional | (105) |
Neutrophil granulocyte | Cytotoxic protein | Tumor cells | Induction of apoptosis | (106) |
Adriamycin | Glioma | No limitations, promising treatments | (107) | |
Macrophages | miRNA | Ovarian cancer | Immune suppression, promote cancer development | (108) |
miR-193a-5p | Tumor cells | Promote tumor invasion | (109) | |
IncRNA | Cancer cells | Aerobic glycolysis, anti-apoptosis ability of cells | (110) | |
Mast cells | KIF protein | Tumor | Promote cancer cell proliferation | (111) |
UCEC, Endometrial cancer.